Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

CITCO

CITCO
CITCO inhibits growth and expansion of brain tumour stem cells (BTSCs) and has an EC50 of 49 nM over pregnane X receptor (PXR), and no activity on other nuclear receptors. CITCO is an imidazothiazole derivative and it also is a selective Constitutive androstane receptor (CAR) agonist.
Catalog No. T14973Cas No. 338404-52-7
Select Batch
Purity:99.24%
Contact us for more batch information

Resource Download

CITCO

Catalog No. T14973Cas No. 338404-52-7

CITCO inhibits growth and expansion of brain tumour stem cells (BTSCs) and has an EC50 of 49 nM over pregnane X receptor (PXR), and no activity on other nuclear receptors. CITCO is an imidazothiazole derivative and it also is a selective Constitutive androstane receptor (CAR) agonist.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Pack SizePriceAvailabilityQuantity
5 mg$57In Stock
10 mg$91In Stock
25 mg$166In Stock
50 mg$266In Stock
100 mg$397In Stock
200 mg$597In Stock
1 mL x 10 mM (in DMSO)$63In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "CITCO"

Product Introduction

Bioactivity
Description
CITCO inhibits growth and expansion of brain tumour stem cells (BTSCs) and has an EC50 of 49 nM over pregnane X receptor (PXR), and no activity on other nuclear receptors. CITCO is an imidazothiazole derivative and it also is a selective Constitutive androstane receptor (CAR) agonist.
In vitro
CITCO (1-50 μM; 48 hours) results in dose-dependent inhibition of viable cell count and proliferation in T98G, U87MG glioma, and BTSCs. CITCO (0-25 μM; 48 hours) significantly increases CAR protein expression in T98G, U87MG glioma, and BTSCs. CITCO (2.5-10 μM; 48 hours) induces apoptosis in BTSCs in a dose-dependent manner, but not in normal astrocytes. CITCO (2.5, 5 μM; 48 hours) induces differential cell cycle arrest in various BTSCs in culture, but not in normal astrocytes[1].
In vivo
CITCO (intraperitoneal; 25?μg; on days 22, 24, 26, 30 and 36) results a significant decrease in tumour growth. After treatment with 100?μg CITCO, it further decreases to an undetectable level [1].
Chemical Properties
Molecular Weight436.74
FormulaC19H12Cl3N3OS
Cas No.338404-52-7
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
H2O: insoluble
DMSO: 11 mg/ml (25.19 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.2897 mL11.4485 mL22.8969 mL114.4846 mL
5 mM0.4579 mL2.2897 mL4.5794 mL22.8969 mL
10 mM0.2290 mL1.1448 mL2.2897 mL11.4485 mL
20 mM0.1145 mL0.5724 mL1.1448 mL5.7242 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy CITCO | purchase CITCO | CITCO cost | order CITCO | CITCO chemical structure | CITCO in vivo | CITCO in vitro | CITCO formula | CITCO molecular weight